DNA from Bacteria, but Not from Vertebrates, Induces Interferons, Activates Natural Killer Cells and Inhibits Tumor Growth

Microbiology and Immunology

Volumn 36, Issue 9, 1992, Pages 983-997

  Yamamoto, Saburo ^a   Kataoka, Tetsuro ^a   Tokunaga, I Tohru ^a   Yamamoto, L Toshiko ^b   Kuramota, Etsuro ^c  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b The Japan Foundation   (Japan)

^c Mitsui Pharmaceuticals Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GAMMA INTERFERON;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CATTLE; FEMALE; MACROPHAGE ACTIVATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; SALMON; SPLEEN CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMAL; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CATTLE; COMPARATIVE STUDY; DNA; DNA, BACTERIAL; FEMALE; IN VITRO; INTERFERONS; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MOLECULAR SEQUENCE DATA; NEOPLASMS, EXPERIMENTAL; POLYDEOXYRIBONUCLEOTIDES; SALMON; SPECIES SPECIFICITY; SUPPORT, NON-U.S. GOV'T;

EID: 0026464967     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1992.tb02102.x     Document Type: Article

References (29)

1. Baeuerle, P. A., and Baltimore, D. 1988. IkB: a specific inhibitor of the NF-kB transcription factor. Science 242: 540–546.
2. Burton, K. 1956. A study of the conditions and mechanism of the diphenylarnine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem.,1. 62: 315–323.
3. Colby, C., and Chamberlin, M. 1969. The specificity of interferon induction in chick embryo cells by helical RNA. Proc. Nati. Acad. Sci. U. S. A. 63: 160–167.
4. Field, A. K., Tytell, A. A., Lampson, G. P., and Hilleman, M. R. 1967. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc. Natl. Acad. Sci. U. S. A. 58: 1004–1010.
5. Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., and Taniguchi, T. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2 bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58: 729–739.
6. Isaacs, A. 1965. Studies on interferon. Aust. J. Biol. Med. Sci. 43: 405-412.
7. Ishihara, K., Ikeda, S., Arao, T., and Matsunaka, M. 1988. A Pilot study on the effect of intralesionally injected MY-I against malignancies of skin. Skin Cancer 3: 115–123.
8. Kataoka, T. Yamamoto, S., Yamamoto, T., Kuramoto, E., Kimura, Y., Yano, O. and Tokunaga, T. 1992. Antitumor activity of synthetic oligonucleotides with sequences from cDNA encoding proteins of Mycobacterium bovis BCG. Ipn. J. Cancer Res. 83: 244-247.
9. Kuramoto, E. Toizumi, S., Shimada, S., and Tokunaga, T. 1989. In situ infiltration of natural killer-like cells induced by intradermal injection of the nucleic acid fraction from BCG. Micro- Immunol. 33: 929–940.
10. Lenard, M., Fan, C. M., Maniatis, T., and Baltimore, D. 1989. The involvement of NF-kB in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 57: 287–294.
11. Marmur, J. 1961. A procedure for the isolation of deoxyribonucleic acid from micro-organisms. J. Mol. Biol. 3:
12. Mashiba, H., Matsunaga, K., Tomoda, H., Furusawa, M., Jimi, S., and Tokunaga, T. 1988. In vitro augmentation of NK activity of peripheral blood cells from cancer patients by a DNA fraction from Mycobacterium bovis BCG. Ton. I. Med. Sci. Biol. 41: 197–202.
13. Messina, J. P., Gilkeson, G. S., and Pisetsky D. S. 1991. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. Immunol. 147: 1759–1764.
14. Ochiai, T., Suzuki, T., Nakajima, K. Asano, T., Mukai, M., Touzu, T., Okuyama, K., Isono, K., Nishijima, H., and Ohkawa, M. 1986. Studies on lymphocyte subsets of regional lymph nodes after endoscopic injection of biological response modifiers in gastric cancer patients. Int. J. Immunotherapy 2: 259–265.
15. Oehler, J. R., and Herberman, R. B. 1978. Natural cell-mediated cytotoxicity in rats. III. Effects of immunopharmacologic treatments on natural reactivity and reactivity augmented by poly- acid. Int. J. Cancer 21: 221–229.
16. Rotem, Z., Cox, R. A., and Isaacs, A. 1963. Inhibition of virus multiplication by foreign nucleic acid. Nature 197: 564-566.
17. Shimada, S., Yano, O., Inoue, H., Kuramoto, E., Fukuda, T., Yamamoto, H., Kataoka, T., and Tokunaga, T. 1985. Antitumor activity of deoxyribonucleic acid from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors. T. Natl. Cancer Inst. 74: 681–688.
18. Shimada, S., Yano, O. and Tokunaga, T. 1986. In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG Jpn., J. Jpn., J. Cancer Res. 77: 808–816.
19. Stein, C. A., and Cohen, J. S. 1988. Oligonucleotides as inhibitors of gene expression. Cancer Res. 48: 2659–2668.
20. Szczylik, C., Skorski, T., Nicolaides, N. C., Manzellia, L., and Malaguarnera, B. 1991. Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligonucleotides. Science 253: 562–565.
21. Taniguchi, T. 1988. Regulation of cytokine gene expression. Annu. Rev. Immunol. 6: 439–464.
22. Tokunaga, T., Yamamoto, H., Shimada, S., Abe, H., Fukuda, T., Fujisawa, Y., Furutani, Y., Yano, 0., Kataoka, T., Sudo, T., Makiguchi, N., and Suganuma, T. 1984. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. I. Natl. Cancer Inst. 72: 955–962.
23. Tokunaga, T., Yamamoto, S., and Namba, K. 1988. A synthetic single-stranded DNA, poly (dG, dC), induces interferon-alpha/beta interferon-alpha/beta and -gamma, augments natural killer activity, and suppresses tumor growth. Jpn. J. Cancer Res. 79: 682–686.
24. Tokunaga, T., Yano, O. Kuramoto, E., Kimura, Y., Yamamoto, T., Kataoka, T., and Yamamoto, S. 1992. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol. Immunol. 36: 55–66.
25. Vilcek, J., Ng, M. H., Friedmann-Kien, A. E. and Krawciw, T. 1968. Induction of interferon synthesis by synthetic double-stranded polynucleotides. J. Vim. 2: 648–650.
26. Watson, I. D., Tooze, J., and Kurtz, D. T. 1983. Transferring genes into mammalian cells, p. 179–180. In Recombinant DNA: a short course, W. H. Freeman and Co., New York.
27. Yamamoto, S., Kuramoto, E., Shimada, S., and Tokunaga, T. 1988. In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn. J. Cancer Res. 79: 866-873.
28. Yamamoto, S., Kataoka, T., Yano, O., Kuramoto, E., Shimada, S., and Tokunaga, T. 1989. Antitumor effect of nucleic acid fraction from bacteria. Proc.,-fpn. Cancer Assoc. 48: 272.
29. Yamamoto, S., Yamamoto, T., Kataoka, T., Kuramoto, E., Yano, O., and Tokunaga, T. 1992. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J. Immunol. 148: 4072–4076.